Literature DB >> 16153925

A randomized comparison of the MCRI On-X and CarboMedics Top Hat bileaflet mechanical replacement aortic valves: early postoperative hemodynamic function and clinical events.

J Chambers1, J Roxburgh, C Blauth, J O'Riordan, F Hodson, H Rimington.   

Abstract

OBJECTIVE: This study compared hemodynamic function and clinical events in consecutive patients randomly assigned to receive a wholly supra-annular replacement valve or a valve with an intra-annular component.
METHODS: Fifty-two patients with an average age of 62 years (range 40-74 years) were sized for both a CarboMedics Top Hat valve (CarboMedics Inc, Austin, Tex) and an MCRI On-X valve (Medical Carbon Research Institute, LLC, Austin, Tex) before random assignment to receive either valve type. Echocardiographic and clinical assessments were performed in the immediate postoperative period and at 1 year.
RESULTS: The mean effective orifice areas were 1.41 +/- 0.42 cm2 for the Top Hat and 2.17 +/- 0.78 cm2 for the On-X (P < .0001). The mean pressure differences were 12.2 +/- 4.4 mm Hg and 6.9 +/- 3.6 mm Hg, respectively (P < .0001). New York Heart Association functional class was better with the On-X than the Top Hat valves, but there were no differences in clinical events, regression of left ventricular mass, or measures of hemolysis.
CONCLUSION: The partially intra-annular MCRI On-X valve was hemodynamically superior to the wholly supra-annular CarboMedics Top Hat valve. However, there were no differences in early clinical outcomes between the two valve types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153925     DOI: 10.1016/j.jtcvs.2005.02.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Left coronary ostial obstruction after aortic valve replacement with a supra-annular aortic valve.

Authors:  Kanji Matsuzaki; Hideya Unno; Taisuke Konishi; Osamu Shigeta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-05

Review 2.  Heart valve replacement: which valve for which patient?

Authors:  Joseph Huh; Faisal Bakaeen
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

3.  Anticoagulation dilemma in a high-risk patient with On-X valves.

Authors:  Ami M Karkar; Manuel R Castresana; Nadine Odo; Shvetank Agarwal
Journal:  Ann Card Anaesth       Date:  2015 Apr-Jun

4.  Impact of patient-prosthesis mismatch on 30-day outcomes in young and middle-aged patients undergoing aortic valve replacement.

Authors:  Daniel Hernández-Vaquero; Juan C Llosa; Rocío Díaz; Zain Khalpey; Carlos Morales; Rubén Álvarez; Jose López; Francisco Boye
Journal:  J Cardiothorac Surg       Date:  2012-05-15       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.